Status:
NOT_YET_RECRUITING
Three-Dimensional Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Breast Cancer
Breast Masses
Eligibility:
All Genders
Brief Summary
The purpose of the study is to test the hypothesis that quantitative ultrasound techniques including spectroscopy may be used as a non-invasive biomarker for characterization of suspected breast cance...
Detailed Description
This project is an observational/early validation study in human subjects that will use ultrasound imaging and spectroscopy to characterize suspected breast cancers. Patients will be imaged with ultra...
Eligibility Criteria
Inclusion
- Women or men with suspected breast cancer
- Patients should have the ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Patients who have had chemotherapy, radiotherapy, or major surgery within 4 weeks prior to registering in the study or those who have not recovered from adverse events due to agents administered more than 4 weeks prior to registration.
- Receiving any other investigational agents.
- Any condition that is unstable or could jeopardize the safety of the patient and their compliance in the study.
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2029
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06175078
Start Date
April 1 2024
End Date
April 1 2029
Last Update
December 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5